Vontobel Holding’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $187K | Hold |
13,356
| – | – | ﹤0.01% | 1048 |
|
2025
Q1 | $209K | Buy |
+13,356
| New | +$209K | ﹤0.01% | 1006 |
|
2024
Q2 | – | Sell |
-21,000
| Closed | -$208K | – | 1078 |
|
2024
Q1 | $208K | Hold |
21,000
| – | – | ﹤0.01% | 994 |
|
2023
Q4 | $67.8K | Sell |
21,000
-28,191
| -57% | -$91.1K | ﹤0.01% | 1060 |
|
2023
Q3 | $261K | Buy |
49,191
+21,125
| +75% | +$112K | ﹤0.01% | 936 |
|
2023
Q2 | $267K | Buy |
28,066
+5,312
| +23% | +$50.6K | ﹤0.01% | 943 |
|
2023
Q1 | $250K | Buy |
22,754
+2,371
| +12% | +$26.1K | ﹤0.01% | 932 |
|
2022
Q4 | $287K | Buy |
20,383
+9,867
| +94% | +$139K | ﹤0.01% | 899 |
|
2022
Q3 | $201K | Buy |
+10,516
| New | +$201K | ﹤0.01% | 950 |
|